Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Medicine, Multiple sclerosis, Alemtuzumab, Physical medicine and rehabilitation, Clinical trial, and Interferon beta-1a.
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial